Best CPAP Machines 2026: Ranked by What You Can Actually Buy

The ResMed AirSense 11 AutoSet keeps first at 9.3 and my ranking holds after last week's React Health shake-up. The news readers keep forwarding me is a sleep apnea pill, so let me put it in context for anyone deciding whether to buy a machine this autumn.

The drug is AD109, a nightly combination of aroxybutynin and atomoxetine that aims to keep throat muscles engaged so the airway stays open. In the phase 3 SynAIRgy trial, 646 adults at 69 sites who had refused or could not tolerate CPAP took it for six months. Their apnea-hypoxia index fell by about 44 percent, against 18 percent on placebo, and 18 percent of patients reached complete disease control. That is a meaningful result for people who have given up on a mask.

The trial's own lead author still calls CPAP the gold standard, and the numbers explain why. A machine used every night brings most patients' events down to a normal range, and it works regardless of what drives the collapse. My advice is this: if you have been diagnosed and your machine is tolerable, keep using it. If you have abandoned CPAP, bring this trial to your sleep physician and ask what it means for you.

Tolerance is what my scoring rewards. The AirSense 11 holds first on its quiet motor, integrated humidifier and a ramp that starts pressure gently, and the AirSense 10 at 8.6 delivers the same comfort features at a lower price. For readers in Taiwan's humid climate, a heated tube cuts rainout noticeably in winter.

Drugwatch counts 624 pending cases in the Philips CPAP litigation as of September 2026. That history is why manufacturer track record and supply continuity sit inside my availability score.

React Health went quiet this week, and my ranking moves because of it. The company folded into AdaptHealth on 1 June 2026, reacthealth.com stopped resolving entirely, and retailers now carry the Luna G3 Auto CPAP with a discontinued-for-2026 label. I have moved it from second place to sixth and cut its availability score from 9.4 to 5.0.

I want to be precise about what changed. The Luna G3 is still the machine I described last week on engineering merit. It takes a standard 22mm hose, it writes full therapy data to an SD card you own, and closeout stock near $849 is real money saved. The factor it lost is the first one I score, which is what you can actually buy and keep running through 2026. A CPAP is a five to seven year commitment that leans on filters, firmware support and a warranty desk that picks up the phone. If you buy remaining stock, plan on sourcing supplies from third parties for the rest of the machine's life.

Transcend fills the gap. The Micro 510 Auto CPAP enters at fifth with 8.0. It weighs 0.48 pounds, runs at 27 dBA, and ships for $829 with a three year warranty, a hard shell case, hypoallergenic filters and the AirMist HME in the box. The detail that earns it 9.5 on mask freedom is the universal 22mm connection, so the mask you already own fits on the first night. Travel size combined with an open supply chain is a rare pairing, and it is why I place it above both travel machines below it.

My top four are otherwise steady. The AirSense 11 AutoSet holds first at 9.3, the AirSense 10 moves up to second at 8.6, and the Resvent iBreeze takes third at 8.3. For readers in Taiwan the Wellell iX-Auto at 8.1 stays the pragmatic answer, with local service and consumables you can buy in person. Talk to your clinician before you change pressure settings or mask style.

The ResMed AirSense 11 AutoSet keeps first place at 9.3 and my ranking holds this week. It is an auto-adjusting CPAP with an integrated heated humidifier, a color touchscreen and the myAir app, which reports nightly hours, mask seal and residual events. It stays on top because it gives new users the most support during the first weeks, which is when most people give up.

That support is getting smarter. ResMed's Smart Comfort feature has FDA clearance as an AI-enabled tool that recommends personalized comfort settings, such as ramp and humidity, to help people start and stay on therapy. ResMed plans a broader US rollout to new myAir users later in 2026. Combined with the ERS 2026 analysis linking each extra nightly hour of PAP use to lower mortality, the logic is clear to me: a machine that keeps you wearing the mask longer is worth paying for.

I also want to address the pill headlines. AD109, an oral drug for obstructive sleep apnea, cut breathing events substantially in a phase 3 trial, with 18 percent of participants reaching complete disease control. That is promising research. It is still a candidate medication, and for anyone diagnosed today, CPAP remains the proven therapy your sleep physician will prescribe. Keep your machine on your nightstand and discuss new options at your next follow-up.

React Health Luna G3 holds second at 8.8 as the best value full-size machine, with a heated humidifier and cellular data included. The AirSense 10 stays third at 8.6 and often costs less where refurbished stock remains available.

In Taiwan, AirSense 11 is sold through licensed medical equipment dealers, so book a pressure trial and mask fitting before you commit to a purchase.

The ResMed AirSense 11 AutoSet keeps first place at 9.3, and the ranking holds this week. It is an auto-adjusting CPAP with a built-in heated humidifier, a touchscreen and the myAir app, which shows your nightly usage, mask seal and events. The reason it stays on top ties directly to this week's research news.

At the European Respiratory Society Congress in Barcelona, held 5 to 9 September, ResMed presented research across the sleep apnea therapy journey. The headline was a late-breaking analysis of a French national database, presented by Prof. Jean-Louis Pépin, which found that each additional hour of nightly PAP use was associated with a lower risk of death among people with obstructive sleep apnea. This is observational data, so it shows an association. Even so, it reinforces the principle I build this ranking on: the best machine is the one you will wear for the whole night.

That is why comfort features and readable data carry so much weight in my scores. AirSense 11 makes nightly hours visible in myAir, and seeing that number every morning is a practical motivator.

The React Health Luna G3 holds second at 8.8. It is an auto CPAP with an integrated humidifier and standard tubing that accepts common masks, and its cash price of $849 makes it my value pick for a full-size machine. The ResMed AirSense 10 AutoSet stays third at 8.6 as a proven workhorse.

The US market structure stays the same. Philips Respironics remains under its consent decree and cannot sell new sleep therapy devices in the United States, so this ranking reflects the machines you can actually buy.

If your usage is slipping, talk to your sleep clinician about mask fit before giving up. A different mask style often fixes the problem.

Buying a CPAP in 2026 starts with a fact that most published rankings still skip. Philips Respironics has been barred from selling new CPAP and BiPAP machines in the United States since the consent decree was entered on 9 April 2024, and the decree runs five years before the company can even petition the court for release. That puts the earliest possible return in 2029. Philips held roughly 37% of the US sleep apnea device market in 2020, so a third of the category walked off the shelf. Any list that still puts a DreamStation at the top is describing a market that closed two years ago. Everything I rank here is a machine you can put in a cart today.

The second thing worth understanding is the price structure, because this category has an unusual one. A DME supplier billing through insurance commonly books an AirSense 11 at around $1,800. ResMed sells the same machine on its own store for $1,054, and cash retailers land between $900 and $1,100. The average private plan deductible passed $1,700 in 2026, so a reader who has not touched their deductible pays the higher of those two numbers and takes on compliance monitoring with it, four hours a night across 70% of nights in the qualifying window. Paying cash drops the monitoring requirement and usually costs less. Medicare is the clean exception: the 2026 Part B deductible is $283 and coverage picks up 80% after that, which makes insurance the better route for anyone on it.

The third thing is that the blower is the small expense. Mask cushions go every two to four weeks, tubing every three months, disposable filters every month. At cash prices that runs about $300 to $800 a year, and following the full Medicare replacement schedule it reaches roughly $1,058. Five years of supplies costs more than any single machine on this list. That is why I weighted hose and mask freedom so heavily. A machine with a standard 22mm fitting lets you shop the entire mask market and switch brands the moment a cushion stops sealing. A proprietary tube ties your supply spending to one vendor for as long as you own the device.

Every machine here requires a prescription in the United States, and any seller shipping without one is worth avoiding. This page compares products, prices and availability. Pressure settings, mode selection and any question about Zepbound belong with a sleep physician.